Spectrofluorimetric determination of cyclic guanosine monophosphate in human nasal secretions: evaluating levels in healthy individuals and patients with olfactory dysfunction
- PMID: 40537874
- PMCID: PMC12180257
- DOI: 10.1186/s13065-025-01530-1
Spectrofluorimetric determination of cyclic guanosine monophosphate in human nasal secretions: evaluating levels in healthy individuals and patients with olfactory dysfunction
Abstract
Cyclic guanosine monophosphate (cGMP) is a second messenger involved in olfactory signal transduction. cGMP levels modulate the sensitivity of olfactory neurons and are implicated in olfactory dysfunctions. Previous reports demonstrate that individuals with olfactory dysfunction exhibit lower cGMP levels in the nasal mucus, necessitating precise analytical quantitative methods. Micellar-based spectrofluorimetric methods improve the detection of low concentrations of fluorescent compounds by using micelles to enhance fluorescence and reduce quenching. This study presents a micellar-based spectrofluorimetric method using Tween 80 to enhance the fluorescence intensity of cGMP. cGMP shows a weak emission signal at 350 nm when excited at 255 nm, but the addition of Tween 80 significantly enhances its fluorescence intensity by forming micelles that solubilize the hydrophobic cGMP and reduce quenching effects. These micelles, created by Tween 80, encapsulate cGMP in a hydrophobic core, stabilizing it through hydrogen bonding and van der Waals interactions, which further enhances fluorescence. The method was evaluated according to ICH M10 guidelines and demonstrated a linear relationship for cGMP concentrations from 1 to 50 ng/mL, with high accuracy and precision across intra-day and inter-day analyses. It also showed high selectivity, accurately detecting cGMP even in the presence of other substances like albumin and lactoferrin. The method was used to determine cGMP levels in the nasal secretions of nine healthy volunteers and eleven patients with olfactory dysfunction, revealing that cGMP was present in both groups. However, the average cGMP levels were significantly lower in patients with olfactory dysfunction (9.89 ± 1.20 ng/mL) compared to healthy individuals (38.65 ± 3.18 ng/mL).
Keywords: Micellar; Nasal; Olfactory dysfunction; cGMP.
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This work was approved by the Committee of Research Ethics in the Faculty of Medicine, Al-Azhar University, Damietta, Egypt. All participants signed informed consent statements before participation in the study. All described procedures were performed in accordance with relevant guidelines and regulations, and in compliance with the Declaration of Helsinki. Consent for publication: Written informed consents were obtained from the participants for publication of this report. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Intra-nasal Disodium Orthophosphate Is Beneficial in Improving Olfactory Dysfunction Post COVID-19.Ann Otol Rhinol Laryngol. 2025 Jun 19:34894251344011. doi: 10.1177/00034894251344011. Online ahead of print. Ann Otol Rhinol Laryngol. 2025. PMID: 40538165
-
Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.Cochrane Database Syst Rev. 2022 Sep 5;9(9):CD013877. doi: 10.1002/14651858.CD013877.pub3. Cochrane Database Syst Rev. 2022. PMID: 36063364 Free PMC article.
-
The Effect and Mechanism of New Processing Method of Codonopsis pilosula on Endocrine Physique Index in Rats.Comput Math Methods Med. 2022 Apr 18;2022:7703612. doi: 10.1155/2022/7703612. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Jun 28;2023:9858791. doi: 10.1155/2023/9858791. PMID: 35479189 Free PMC article. Retracted.
-
Aetiological relationships of nasal mucus cyclic nucleotides in patients with taste and smell dysfunction.J Clin Pathol. 2012 May;65(5):447-51. doi: 10.1136/jclinpath-2012-200698. Epub 2012 Feb 22. J Clin Pathol. 2012. PMID: 22362840
-
Olfactory Dysfunction Following Moderate to Severe Traumatic Brain Injury: A Systematic Review and Meta-Analysis.Neuropsychol Rev. 2023 Dec;33(4):717-732. doi: 10.1007/s11065-022-09563-2. Epub 2022 Sep 7. Neuropsychol Rev. 2023. PMID: 36070126 Free PMC article.
References
-
- Behera G, Mishra B, Behera P, Panda M. Fluorescent probes for structural and distance effect studies in micelles, reversed micelles and microemulsions. Adv Colloid Interface Sci. 1999;82(1–3):1–42.
-
- Ghosh S, Banik D, Roy A, Kundu N, Kuchlyan J, Sarkar N. Spectroscopic investigation of the binding interactions of a membrane potential molecule in various supramolecular confined environments: contrasting behavior of surfactant molecules in relocation or release of the probe between nanocarriers and DNA surface. Phys Chem Chem Phys. 2014;16(45):25024–38. - PubMed
-
- Henkin R, Velicu I. cAMP and cGMP in nasal mucus related to severity of smell loss in patients with smell dysfunction. Clin Invest Med. 2008;31(2):E78–84. - PubMed
-
- Moon C, Simpson PJ, Tu Y, Cho H, Ronnett GV. Regulation of intracellular Cyclic GMP levels in olfactory sensory neurons. J Neurochem. 2005;95(1):200–9. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources